Sichuan Goldstone Asia Pharmaceutical's shift to profitabili...
Sichuan Goldstone Asia Pharmaceutical's shift to profitability has likely led to a more positive market perception, evidenced by its share price growth. The overall sentiment around the company appears to have recently improved considering the increased total shareholder return (TSR).
![](https://pubimg-10000538.picsh.myqcloud.com/2022050900000151d6556550869.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment